🇺🇸 FDA
Pipeline program

Herbal Medicine C-117

2014A020221074

Phase 2 small_molecule active

Quick answer

Herbal Medicine C-117 for Occlusion and Stenosis of Unspecified Cerebral Artery is a Phase 2 program (small_molecule) at China SXT Pharmaceuticals with 1 ClinicalTrials.gov record(s).

Program details

Company
China SXT Pharmaceuticals
Indication
Occlusion and Stenosis of Unspecified Cerebral Artery
Phase
Phase 2
Modality
small_molecule
Status
active

Clinical trials